InfuSystem Holdings, Inc.
INFU · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.86 | -0.01 | 0.83 | -1.00 |
| FCF Yield | 3.91% | 5.19% | 1.45% | 1.57% |
| EV / EBITDA | -100.51 | 22.02 | 37.17 | 33.51 |
| Quality | ||||
| ROIC | 6.37% | 5.54% | 2.14% | 1.23% |
| Gross Margin | 57.06% | 55.20% | 55.21% | 53.82% |
| Cash Conversion Ratio | 3.76 | 2.70 | -6.67 | 8.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.72% | 5.77% | 6.62% | 7.06% |
| Free Cash Flow Growth | 23.88% | 311.89% | -41.57% | -71.20% |
| Safety | ||||
| Net Debt / EBITDA | -9.98 | 4.08 | 8.10 | 4.50 |
| Interest Coverage | -2.03 | 7.51 | 1.84 | 7.25 |
| Efficiency | ||||
| Inventory Turnover | 2.80 | 2.85 | 2.55 | 2.39 |
| Cash Conversion Cycle | 34.49 | 40.83 | 48.79 | 37.14 |